NeuroVia raises $14M in series A

Rare disease company NeuroVia Inc. (San Francisco, Calif.) raised $14 million on July 20 in a series A round led by Novartis Venture Fund (NVF) and Sanofi-Genzyme BioVentures (SGBV). Also participati...